DexCom, Inc. (ETR:DC4)

Market Cap	18.52B
Revenue (ttm)	3.85B
Net Income (ttm)	614.25M
Shares Out	n/a
EPS (ttm)	1.53
PE Ratio	30.16
Forward PE	22.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	177
Average Volume	583
Open	50.19
Previous Close	50.20
Day's Range	46.88 - 50.40
52-Week Range	46.88 - 88.54
Beta	n/a
RSI	28.97
Earnings Date	Oct 30, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DC4

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD